ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
05 11 2019
Historique:
entrez: 2 11 2019
pubmed: 2 11 2019
medline: 15 12 2020
Statut: ppublish

Résumé

Background Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF-less individuals is not uncommon. This study uses 2 sequential large, multicenter registries to examine the proportion and outcomes of SMuRF-less ST-segment-elevation myocardial infarction (STEMI) patients. Methods and Results We identified 3081 STEMI patients without a prior history of cardiovascular disease in the Australian GRACE (Global Registry of Acute Coronary Events) and CONCORDANCE (Cooperative National Registry of Acute Coronary Syndrome Care) registries, encompassing 42 hospitals, between 1999 and 2017. We examined the proportion that were SMuRF-less as well as outcomes. The primary outcome was in-hospital mortality, and the secondary outcome was major adverse cardiovascular events (death, myocardial infarction, or heart failure, during the index admission). Multivariate regression models were used to identify predictors of major adverse cardiovascular events. Of STEMI patients without a prior history of cardiovascular disease 19% also had no history of SMuRFs. This proportion increased from 14% to 23% during the study period (

Identifiants

pubmed: 31672080
doi: 10.1161/JAHA.119.013296
pmc: PMC6898813
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e013296

Références

J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):4-24
pubmed: 13411327
J Am Heart Assoc. 2019 Nov 5;8(21):e013296
pubmed: 31672080
Arch Intern Med. 2006 Jul 10;166(13):1368-73
pubmed: 16832001
Eur Heart J. 2014 Sep 1;35(33):2232-41
pubmed: 24366919
Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830
pubmed: 28703626
Heart Lung Circ. 2018 Dec;27(12):1398-1405
pubmed: 29066011
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
JAMA. 2011 Nov 16;306(19):2120-7
pubmed: 22089719
Ann Intern Med. 1961 Jul;55:33-50
pubmed: 13751193
Eur J Intern Med. 2013 Jun;24(4):295-302
pubmed: 23647842
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Am Heart J. 2007 Apr;153(4):507-14
pubmed: 17383286
Vasc Health Risk Manag. 2007;3(5):629-37
pubmed: 18078014
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Can J Cardiol. 2015 Dec;31(12):1455-61
pubmed: 26143140
Microcirculation. 2019 Feb;26(2):e12488
pubmed: 29956866
JAMA. 2003 Aug 20;290(7):898-904
pubmed: 12928466
Environ Res. 2017 Nov;159:16-23
pubmed: 28763730
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72
pubmed: 25766941
Heart. 2010 Jul;96(14):1095-101
pubmed: 20511625
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302
pubmed: 29141201
J Am Coll Cardiol. 2017 Dec 19;70(24):2979-2991
pubmed: 29241485
Am J Cardiol. 2002 Aug 15;90(4):358-63
pubmed: 12161222
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
J Am Coll Cardiol. 2016 May 24;67(20):2411-2418
pubmed: 27199065
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Eur Heart J. 2002 Aug;23(15):1190-201
pubmed: 12127921
JAMA. 2007 Feb 14;297(6):611-9
pubmed: 17299196

Auteurs

Stephen T Vernon (ST)

Cardiothoracic and Vascular Health Kolling Institute and Department of Cardiology Royal North Shore Hospital Northern Sydney Local Health District St Leonards Australia.
Charles Perkins Centre University of Sydney Australia.

Sean Coffey (S)

Dunedin School of Medicine University of Otago Dunedin New Zealand.

Mario D'Souza (M)

School of Public Health Clinical Research Centre Sydney Local Health District University of Sydney Australia.

Clara K Chow (CK)

Westmead Applied Research Centre Faculty of Medicine and Health University of Sydney Australia.
Department of Cardiology Westmead Hospital Sydney Australia.

Jens Kilian (J)

Bankstown Hospital Sydney Australia.

Karice Hyun (K)

Westmead Applied Research Centre Faculty of Medicine and Health University of Sydney Australia.

James A Shaw (JA)

Department of Cardiovascular Medicine The Alfred Hospital Melbourne VIC Australia.

Mark Adams (M)

Department of Cardiology Royal Prince Alfred Hospital Sydney Australia.

Philip Roberts-Thomson (P)

Menzies Institute for Medical Research University of Tasmania Hobart Australia.
Royal Hobart Hospital Hobart Australia.

David Brieger (D)

Cardiology Department Concord Repatriation General Hospital Sydney Australia.

Gemma A Figtree (GA)

Cardiothoracic and Vascular Health Kolling Institute and Department of Cardiology Royal North Shore Hospital Northern Sydney Local Health District St Leonards Australia.
Charles Perkins Centre University of Sydney Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH